Nuanced Roles of Cytokines in Three Major Human Brain Disorders

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2008 Nov 5

PMID 18982162

Citations 46

Authors

Lawrence Steinman

Affiliations

Soon will be listed here.

Abstract

The three most prevalent human disorders of the CNS in which immunity and inflammation are likely to have vital roles (excluding infection of the CNS) are fever, multiple sclerosis (MS), and Alzheimer disease (AD). As reviewed here, cytokines are critical in the induction of fever, the pathogenesis of MS, and the pathobiology of AD. Indeed, antibodies targeting cytokines have been used as a therapy for individuals with unusual and persistent febrile reactions not responsive to common antipyretics, while a recombinant cytokine is the most popular treatment for the relapsing-remitting form of MS. Although cytokine-modulating therapies are not currently in clinical use for the treatment of AD, cytokines can ameliorate disease pathology in certain experimental models of AD, suggesting a potential for future therapeutic opportunities.

Citing Articles

Role of IRF4-Mediated Inflammation: Implication in Neurodegenerative Diseases.

Mamun A, Liu F Neurol Neurother Open Access J. 2024; 2(1).

PMID: 39473489 PMC: 11521387. DOI: 10.23880/nnoaj-16000107.

Aging mitochondria in the context of SARS-CoV-2: exploring interactions and implications.

Delpino M, Quarleri J Front Aging. 2024; 5:1442323.

PMID: 39380657 PMC: 11458564. DOI: 10.3389/fragi.2024.1442323.

Effects of transcranial direct current stimulation on brain cytokine levels in rats.

Ethridge V, Gargas N, Sonner M, Moore R, Romer S, Hatcher-Solis C Front Neurosci. 2023; 16:1069484.

PMID: 36620466 PMC: 9822516. DOI: 10.3389/fnins.2022.1069484.

LPS-Induced Inhibition of miR-143 Expression in Brown Adipocytes Promotes Thermogenesis and Fever.

Liu J, Zeng D, Luo J, Wang H, Xiong J, Chen X Int J Mol Sci. 2022; 23(22).

PMID: 36430282 PMC: 9696956. DOI: 10.3390/ijms232213805.

Connecting aging biology and inflammation in the omics era.

Walker K, Basisty N, Wilson 3rd D, Ferrucci L J Clin Invest. 2022; 132(14).

PMID: 35838044 PMC: 9282936. DOI: 10.1172/JCI158448.

References

Wyss-Coray T, Lin C, Yan F, Yu G, Rohde M, McConlogue L . TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med. 2001; 7(5):612-8. DOI: 10.1038/87945. View

Kirichuk V, Streknev A . [The role of hemostasis system in the pathogenesis and course of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2003; (Spec No 2):34-8. View

Ma Z, Qin H, Benveniste E . Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol. 2001; 167(9):5150-9. DOI: 10.4049/jimmunol.167.9.5150. View

Chabas D, Baranzini S, Mitchell D, Bernard C, Rittling S, Denhardt D . The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 2001; 294(5547):1731-5. DOI: 10.1126/science.1062960. View

Feldmann M, Maini R . Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med. 2003; 9(10):1245-50. DOI: 10.1038/nm939. View

Steinman L . Elaborate interactions between the immune and nervous systems. Nat Immunol. 2004; 5(6):575-81. DOI: 10.1038/ni1078. View

Vogt M, Floris S, Killestein J, Knol D, Smits M, Barkhof F . Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients. J Neuroimmunol. 2004; 155(1-2):155-60. DOI: 10.1016/j.jneuroim.2004.06.007. View

Dinarello C . Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 2004; 10(4):201-22. DOI: 10.1179/096805104225006129. View

Dinarello C, Wolff S . Molecular basis of fever in humans. Am J Med. 1982; 72(5):799-819. DOI: 10.1016/0002-9343(82)90548-4. View

10.

Dinarello C . Interleukin-1. Rev Infect Dis. 1984; 6(1):51-95. DOI: 10.1093/clinids/6.1.51. View

11.

Lomedico P, Gubler U, Hellmann C, Dukovich M, Giri J, Pan Y . Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature. 1984; 312(5993):458-62. DOI: 10.1038/312458a0. View

12.

Auron P, Webb A, Rosenwasser L, Mucci S, Rich A, Wolff S . Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci U S A. 1984; 81(24):7907-11. PMC: 392262. DOI: 10.1073/pnas.81.24.7907. View

13.

Panitch H, Hirsch R, Schindler J, Johnson K . Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 1987; 37(7):1097-102. DOI: 10.1212/wnl.37.7.1097. View

14.

Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, SOBIS H, MEULEPAS E . Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol. 1988; 140(5):1506-10. View

15.

Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L . Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989; 86(19):7611-5. PMC: 298116. DOI: 10.1073/pnas.86.19.7611. View

16.

Harlos K, Martin D, OBrien D, Jones E, Stuart D, Polikarpov I . Crystal structure of the extracellular region of human tissue factor. Nature. 1994; 370(6491):662-6. DOI: 10.1038/370662a0. View

17.

Gijbels K, Galardy R, Steinman L . Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest. 1994; 94(6):2177-82. PMC: 330042. DOI: 10.1172/JCI117578. View

18.

Hebert L, Scherr P, Beckett L, Albert M, Pilgrim D, Chown M . Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995; 273(17):1354-9. View

19.

Fekade D, Knox K, Hussein K, Melka A, Lalloo D, Coxon R . Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996; 335(5):311-5. DOI: 10.1056/NEJM199608013350503. View

20.

Krakowski M, Owens T . Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol. 1996; 26(7):1641-6. DOI: 10.1002/eji.1830260735. View